Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F9NK6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,581
Award facts
- Contract value 100% obligated
- $14,581.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,581.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 28, 2026, for Cosentyx (secukinumab) 300mg dose auto-injector pens. The order is expected to be completed by January 29, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal procurement requirements for pharmaceutical products through open competition.
This task order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (contract value up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (the parent entity), which is a major pharmaceutical distributor providing essential medications and medical supplies to federal agencies including the Department of Defense and Department of Veterans Affairs. The delivery of Cosentyx, a specialty biologic medication used primarily for autoimmune and inflammatory conditions, exemplifies the contractor's role in supplying specialized pharmaceutical commodities to support military medical treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9NK6?
SPE2DR26F9NK6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F9NK6 worth?
The government has obligated $14,581 on SPE2DR26F9NK6.
Is contract SPE2DR26F9NK6 an order under another contract?
Yes. SPE2DR26F9NK6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NK6 competed?
The extent of competition for SPE2DR26F9NK6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award